Interview with Dr David Orloff - Pharmaceutical Business Review

Links shared publicly online about this topic.

  • 52
    total visits

Interview with Dr David Orloff - Pharmaceutical Business Review

pharmaceutical-business-review.com

Close Concerns recently had the distinct honor of discussing the recent FDA cardiovascular risk assessment guidelines for diabetes drugs with Dr. Davi

View full resource at pharmaceutical-business-review.com

Tags: Heart, Diabetes, Diabetes Medication, Drug, Pharma, FDA

  • Share

Most Recently Shared on August 23, 2011 at 10:09 am By:

EndocrinologyOW Endocrinology Wisdom

Interview with Dr David Orloff: Close Concerns recently had the distinct honor of discussing the recent FDA card... http://t.co/XCQKLAU

8 months ago...

Advertisement